v3.21.2
CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) - USD ($)
Jun. 30, 2021
Mar. 31, 2021
Current assets    
Cash $ 25,171,679 $ 9,861,575
Accounts receivable 131,966 149,082
Prepaid expenses and other current assets 244,121 341,081
Total current assets 25,547,766 10,351,738
Property and equipment, net 187,821 160,976
Right-of-use lease asset 15,722 40,363
Patents, net 56,817 56,954
Restricted cash 46,726 46,726
Deposits 12,159 12,159
Total assets 25,867,011 10,668,916
Current liabilities    
Accounts payable 243,650 337,678
Due to related parties 119,578 118,520
Deferred revenue 114,849 114,849
Lease liability, current portion 16,835 42,543
Other current liabilities 636,387 761,636
Total current liabilities 1,131,299 1,375,226
Stockholders’ Equity    
Common stock, par value $0.001 per share; 30,000,000 shares authorized; 15,386,367 and 12,150,597 shares issued and outstanding as of June 30, 2021 and March 31, 2021, respectively 15,388 12,152
Additional paid-in capital 146,868,766 129,331,542
Accumulated deficit (122,010,393) (119,913,090)
Total Aethlon Medical, Inc. stockholders’ equity before noncontrolling interests 24,873,761 9,430,604
Noncontrolling interests (138,049) (136,914)
Total stockholders’ equity 24,735,712 9,293,690
Total liabilities and stockholders’ equity $ 25,867,011 $ 10,668,916

Source